Life sciences companies stand to gain from a surge in artificial intelligence fueled drug discovery, says Citrini Research after testing Anthropic’s Claude Science
bloom.bgCitrini Bets on Life Sciences Stocks After Claude AI Drug StudyLife sciences companies stand to gain from a surge in artificial intelligence fueled drug discovery, says Citrini Research after testing Anthropic PBC’s Claude Science.
3 reposts8 likes